Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

Gregory Y. H. Lip; Julius Nikorowitsch; Susanne Sehner; Nina Becher; Emanuele Bertaglia; Carina Blomstrom-Lundqvist; Axel Brandes; Vincent Beuger; Melanie Calvert; A. John Camm; Gregory Chlouverakis; Gheorghe-Andrei Dan; Wolfgang Dichtl; Hans Christoph Diener; Alexander Fierenz; Andreas Goette; Joris R. de Groot; Astrid Hermans; Andrzej Lubinski; Eloi Marijon; Béla Merkely; Lluís Mont; Ann-Kathrin Ozga; Kim Rajappan; Andrea Sarkozy; Daniel Scherr; Renate B. Schnabel; Ulrich Schotten; Emmanuel Simantirakis; Tobias Toennis; Panos Vardas; Dan Wichterle; Antonia Zapf; Paulus Kirchhof; NOAH-AFNET 6 Investigators

doi:10.1093/eurheartj/ehae225

Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

Gregory Y. H. Lip, Julius Nikorowitsch, Susanne Sehner, Nina Becher, Emanuele Bertaglia, Carina Blomstrom-Lundqvist, Axel Brandes, Vincent Beuger, Melanie Calvert, A. John Camm, Gregory Chlouverakis, Gheorghe-Andrei Dan, Wolfgang Dichtl, Hans Christoph Diener, Alexander Fierenz, Andreas Goette, Joris R. de Groot, Astrid Hermans, Andrzej Lubinski, Eloi MarijonBéla Merkely, Lluís Mont, Ann-Kathrin Ozga, Kim Rajappan, Andrea Sarkozy, Daniel Scherr, Renate B. Schnabel, Ulrich Schotten, Emmanuel Simantirakis, Tobias Toennis, Panos Vardas, Dan Wichterle, Antonia Zapf, Paulus Kirchhof^*, NOAH-AFNET 6 Investigators

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

10 Downloads (Pure)

Original language	English
Article number	ehae225
Journal	European Heart Journal
Volume	45
Issue number	19
Pages (from-to)	1733-1737
Number of pages	5
ISSN	0195-668X
DOIs	https://doi.org/10.1093/eurheartj/ehae225
Publication status	Published - 21 May 2024

Keywords

Administration, Oral
Age Factors
Aged
Anticoagulants/administration & dosage
Atrial Fibrillation/drug therapy
Cardiovascular Diseases/prevention & control
Comorbidity
Female
Humans
Male
Sex Factors
Stroke/prevention & control
Treatment Outcome

Access to Document

10.1093/eurheartj/ehae225Licence: CC BY-NC 4.0

Lip et al. (2024). Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trialFinal published version, 2.2 MBLicence: CC BY-NC 4.0

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Lip, G. Y. H., Nikorowitsch, J., Sehner, S., Becher, N., Bertaglia, E., Blomstrom-Lundqvist, C., Brandes, A., Beuger, V., Calvert, M., Camm, A. J., Chlouverakis, G., Dan, G.-A., Dichtl, W., Diener, H. C., Fierenz, A., Goette, A., de Groot, J. R., Hermans, A., Lubinski, A., ... NOAH-AFNET 6 Investigators (2024). Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial. European Heart Journal, 45(19), 1733-1737. Article ehae225. https://doi.org/10.1093/eurheartj/ehae225

@article{c486d3bce2534d7cb419d96a95cb7b4a,

title = "Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial",

keywords = "Administration, Oral, Age Factors, Aged, Anticoagulants/administration & dosage, Atrial Fibrillation/drug therapy, Cardiovascular Diseases/prevention & control, Comorbidity, Female, Humans, Male, Sex Factors, Stroke/prevention & control, Treatment Outcome",

author = "Lip, {Gregory Y. H.} and Julius Nikorowitsch and Susanne Sehner and Nina Becher and Emanuele Bertaglia and Carina Blomstrom-Lundqvist and Axel Brandes and Vincent Beuger and Melanie Calvert and Camm, {A. John} and Gregory Chlouverakis and Gheorghe-Andrei Dan and Wolfgang Dichtl and Diener, {Hans Christoph} and Alexander Fierenz and Andreas Goette and {de Groot}, {Joris R.} and Astrid Hermans and Andrzej Lubinski and Eloi Marijon and B{\'e}la Merkely and Llu{\'i}s Mont and Ann-Kathrin Ozga and Kim Rajappan and Andrea Sarkozy and Daniel Scherr and Schnabel, {Renate B.} and Ulrich Schotten and Emmanuel Simantirakis and Tobias Toennis and Panos Vardas and Dan Wichterle and Antonia Zapf and Paulus Kirchhof and {NOAH-AFNET 6 Investigators}",

year = "2024",

month = may,

day = "21",

doi = "10.1093/eurheartj/ehae225",

language = "English",

volume = "45",

pages = "1733--1737",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "19",

}

Lip, GYH, Nikorowitsch, J, Sehner, S, Becher, N, Bertaglia, E, Blomstrom-Lundqvist, C, Brandes, A, Beuger, V, Calvert, M, Camm, AJ, Chlouverakis, G, Dan, G-A, Dichtl, W, Diener, HC, Fierenz, A, Goette, A, de Groot, JR, Hermans, A, Lubinski, A, Marijon, E, Merkely, B, Mont, L, Ozga, A-K, Rajappan, K, Sarkozy, A, Scherr, D, Schnabel, RB, Schotten, U, Simantirakis, E, Toennis, T, Vardas, P, Wichterle, D, Zapf, A, Kirchhof, P & NOAH-AFNET 6 Investigators 2024, 'Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial', European Heart Journal, vol. 45, no. 19, ehae225, pp. 1733-1737. https://doi.org/10.1093/eurheartj/ehae225

Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial. / Lip, Gregory Y. H.; Nikorowitsch, Julius; Sehner, Susanne et al.
In: European Heart Journal, Vol. 45, No. 19, ehae225, 21.05.2024, p. 1733-1737.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

AU - Lip, Gregory Y. H.

AU - Nikorowitsch, Julius

AU - Sehner, Susanne

AU - Becher, Nina

AU - Bertaglia, Emanuele

AU - Blomstrom-Lundqvist, Carina

AU - Brandes, Axel

AU - Beuger, Vincent

AU - Calvert, Melanie

AU - Camm, A. John

AU - Chlouverakis, Gregory

AU - Dan, Gheorghe-Andrei

AU - Dichtl, Wolfgang

AU - Diener, Hans Christoph

AU - Fierenz, Alexander

AU - Goette, Andreas

AU - de Groot, Joris R.

AU - Hermans, Astrid

AU - Lubinski, Andrzej

AU - Marijon, Eloi

AU - Merkely, Béla

AU - Mont, Lluís

AU - Ozga, Ann-Kathrin

AU - Rajappan, Kim

AU - Sarkozy, Andrea

AU - Scherr, Daniel

AU - Schnabel, Renate B.

AU - Schotten, Ulrich

AU - Simantirakis, Emmanuel

AU - Toennis, Tobias

AU - Vardas, Panos

AU - Wichterle, Dan

AU - Zapf, Antonia

AU - Kirchhof, Paulus

AU - NOAH-AFNET 6 Investigators

PY - 2024/5/21

Y1 - 2024/5/21

KW - Administration, Oral

KW - Age Factors

KW - Aged

KW - Anticoagulants/administration & dosage

KW - Atrial Fibrillation/drug therapy

KW - Cardiovascular Diseases/prevention & control

KW - Comorbidity

KW - Female

KW - Humans

KW - Male

KW - Sex Factors

KW - Stroke/prevention & control

KW - Treatment Outcome

UR - http://www.scopus.com/inward/record.url?scp=85193977276&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehae225

DO - 10.1093/eurheartj/ehae225

M3 - Letter

C2 - 38591192

SN - 0195-668X

VL - 45

SP - 1733

EP - 1737

JO - European Heart Journal

JF - European Heart Journal

IS - 19

M1 - ehae225

ER -

Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

Keywords

Access to Document

AUB Link

Other files and links

Cite this